Clinical Manifestations and Complications of Dengue Infection in Children: Insights and Comparisons with Adult Cases

Literature Review

Authors

  • Sonia Sudana Kusuma General Practitioner, Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v52i8.1518

Keywords:

Children, complications, dengue fever, dengue hemorrhagic fever, dengue shock syndrome

Abstract

Dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) have become significant global health concerns, particularly affecting children more severely than adults. In children, dengue infection is distinct from that in adults due to its higher mortality rate and increased risk of developing dengue hemorrhagic fever or dengue shock syndrome. Clinical manifestations vary by age; children more commonly present with vomiting, rash, and abdominal pain, while adults often experience muscle and joint pain. Symptoms of DHF, a severe type of dengue infection, include abnormal hemostasis, plasma leakage, and protein-losing shock syndrome (dengue shock syndrome/DSS). Dengue infection in children can cause various complications from each organ system. During the critical phase, children are prone to plasma leakage, shock, and bleeding, potentially leading to severe complications such as liver dysfunction, electrolyte imbalance, and organ failure. Proper management and prevention of dengue are required to prevent dengue complications.

Downloads

Download data is not yet available.

References

Schaefer TJ, Panda PK, Wolford RW. Dengue fever. StatPearls [Internet]. 2024 [cited 2024 Jul 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430732/.

Mikhael K, Husada D, Lestari P. Profile of dengue fever complication in infant at tertiary referral hospital in East Java, Indonesia. Biomolecular and Health Science Journal. 2022 Apr 28;5(1):11–5. doi: 10.20473/bhsj.v5i1.34827.

World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. New Delhi: WHO Regional Office for South-East Asia; 2011 .p. 196.

Halstead SB. Dengue fever and dengue hemorrhagic fever. In: Kliegman RM, Geme JW, editors. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier Health Sciences; 2019. p. 1629-32.

Florez JES, Velasquez KM, Cardona AMS, Jaramillo BNR, Diaz YEO, Cardona LSG, et al. Clinical manifestations of dengue in children and adults in a hyperendemic region of Colombia. AJTMH [Internet]. 2024 [cited 2024 Jul 29]. Available from: https://www.ajtmh.org/view/journals/tpmd/110/5/article-p971.xml.

Badan Kebijakan Pembangunan Kesehatan, BKPK Kementerian Kesehatan Republik Indonesia. SKI 2023 dalam angka [Internet]. Jakarta: BKPK Kemenkes; 2023 [cited 2024 Jul 29]. Available from: https://www.badankebijakan.kemkes.go.id/ski-2023-dalam-angka/.

Mishra S, Ramanathan R, Agarwalla SK. Clinical profile of dengue fever in children: A study from Southern Odisha, India. Scientifica (Cairo) 2016;2016:6391594. doi: 10.1155/2016/6391594.

Guzmán MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002 Jun;6(2):118–24. doi: 10.1016/s1201-9712(02)90072-x.

Arlinta D. The trend of death rates due to dengue fever is increasing [Internet]. Jakarta: Kompas.id; 2023 [cited 2024 Jul 29]. Available from: https://www.kompas.id/baca/english/2023/09/08/en-tren-angka-kematian-akibat-dbd-meningkat.

Vinmec International Hospital. Dengue fever: which state is the most dangerous? [Internet]. [cited 2024 Jul 29]. Available from: https://www.vinmec.com/eng/blog/dengue-fever-what-is-the-most-dangerous-stage-en/.

Hanafusa S, Chanyasanha C, Sujirarat D, Khuankhunsathid I, Yaguchi A, Suzuki T. Clinical features and differences between child and adult dengue infections in Rayong Province, southeast Thailand. Southeast Asian J Trop Med Public Health [Internet]. 2008 Mar;39(2):252–9. Available from: https://www.tm.mahidol.ac.th/seameo/2008_39_2/10-4057.pdf.

de Souza LJ, Bastos Pessanha L, Carvalho Mansur L, Assed de Souza L, Barbosa Tamega Ribeiro M, et al. Comparison of clinical and laboratory characteristics between children and adults with dengue. The Brazilian Journal of Infectious Diseases 2013 Jan 1;17(1):27–31. doi: 10.1016/j.bjid.2012.08.020.

Namvongsa V, Sirivichayakul C, Songsithichok S, Chanthavanich P, Chokejindachai W, Sitcharungsi R. Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health [Internet]. 2013 Sep;44(5):772–9. Available from: https://search.tci-thailand.org/article.html?b3BlbkFydGljbGUmaWQ9MTIwNTQx.

Centers for Disease Control and Prevention (CDC). Clinical features of dengue [Internet]. Atlanta (GA): CDC; 2024 [cited 2024 Jul 30]. Available from: https://www.cdc.gov/dengue/hcp/clinical-signs/index.html

Sandinirwan I, Muslim B, Leo H, Hasanah H, Karina PP. Evaluating the importance of clinical manifestations and laboratory parameters associated with progression to severe dengue in children. Paediatrica Indonesiana 2023 Apr 11;63(2):102–18. doi: 10.14238/pi63.2.2023.102-18.

White NJ, Halstead SB. Dengue. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: Elsevier; 2011. p. 1257-73.

Deen J, Seidlein L von. Paracetamol for dengue fever: no benefit and potential harm? The Lancet Global Health 2019 May 1;7(5):e552–3. doi: 10.1016/S2214-109X(19)30157-3.

Tayal A, Kabra SK, Lodha R. Management of dengue: an updated review. Indian J Pediatr. 2023;90(2):168–77. doi: 10.1007/s12098-022-04394-8.

Sharma A, Ali M. Prophylactic platelet transfusion in dengue: blanket of false comfort? Natl Med J India. 2018 Jan 1;31:24. doi: 10.4103/0970-258X.243409.

UNICEF South Asia. Dengue: how to keep children safe [Internet]. Kathmandu: UNICEF South Asia [cited 2024 Jul 31]. Available from: https://www.unicef.org/rosa/stories/dengue-how-keep-children-safe.

World Health Organization (WHO). Vaccines and immunization: dengue [Internet]. Geneva: WHO; 2023 [cited 2024 Jul 31]. Available from: https://www.who.int/news-room/questions-and-answers/item/dengue-vaccines.

Utarini A, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Ansari MR, et al. Efficacy of Wolbachia-infected mosquito deployments for the control of dengue. N Engl J Med. 2021;384(23):2177–86. doi: 10.1056/NEJMoa2030243.

Manjarres-Suarez A, Olivero-Verbel J. Chemical control of Aedes aegypti: a historical perspective. Revista Costarricense de Salud Publica. 2013;22(1):68–75.

Downloads

Published

08-08-2025

How to Cite

Kusuma, S. S. (2025). Clinical Manifestations and Complications of Dengue Infection in Children: Insights and Comparisons with Adult Cases: Literature Review. Cermin Dunia Kedokteran, 52(8), 517–520. https://doi.org/10.55175/cdk.v52i8.1518